TABLE 2.

Primary, secondary, and other predefined endpoints^a

Endpoint	Median (IQR) or no. (%)		P value
	Pre-AXDX group (n = 84)	Post-AXDX group (n = 89)
Time to first antibiotic intervention (h)	26.3 (4.5–43.6)	8 (6.5–11.3)	0.003
Time to most targeted therapya (h)	14.4 (0–49.6)	9.0 (0–18.5)	0.03
14-day mortality	3 (3.6)	0	0.11
Hospital LOS (days)	8 (6–10.75)	6 (4.5–8.5)	0.002
Hospital LOS post-positive BCb (days)	6 (4–9)	5 (3–7)	0.01
ICU LOS post-positive BC (days)	3 (2–6.25)	2 (2–2.5)	0.25
Antibiotic intensity scorec	16 (10.5–20)	12 (9–15.5)	0.0002
30-day readmission	7 (8.6)	5 (5.6)	0.44
Broad-spectrum antibiotics (days)	3 (2–3)	1 (0.5–2)	<0.0001

^aAfter positive blood cultures.

^bBC, blood cultures.

^cCalculated at 96 h of antibiotic therapy.